drugset / Trial / NCT00280566
Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if ziprasidone plus a mood stabilizer will continue to be a safe and effective treatment regimen for adults with Bipolar I Disorder (manic or mixed symptoms) after they have achieved 8 consecutive weeks of symptom improvement on the regimen.
Timeline
- Start
- 2005-12
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ziprasidone | Small molecule | 40 mg | Oral |
| Subject | Ziprasidone | Small molecule | 60 mg | Oral |
| Subject | Ziprasidone | Small molecule | 80 mg | Oral |